Status:
COMPLETED
A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
Lead Sponsor:
Dow Pharmaceutical Sciences
Conditions:
Acne Vulgaris
Eligibility:
All Genders
12-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Eligibility Criteria
Inclusion
- Presence of inflammatory and non-inflammatory lesions
Exclusion
- Dermatological conditions of the face other than acne that could interfere with clinical evaluations
- Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1399 Patients enrolled
Trial Details
Trial ID
NCT00663286
Start Date
October 1 2006
Last Update
April 22 2008
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Burke Pharmaceutical Research
Hot Springs, Arkansas, United States, 71913
2
The Savin Center, PC
New Haven, Connecticut, United States, 06511
3
Webster Dermatology, PA
Hockessin, Delaware, United States, 19707
4
Skin Care Research, Inc.
Boca Raton, Florida, United States, 33486